Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of sulfonyl benzoic acid derivatives with joint TGR5-agonist and FXR-antagonist activity for myocardial ischemia/reperfusion injury protection.

Acta pharmaceutica Sinica. B·2026
Same author

An Overview of the Research Status and Advances in Precision Feeding Technology and Equipment in Aquaculture.

Animals : an open access journal from MDPI·2026
Same author

Programmable enhancement of endogenous mRNA translation through CRISPR-guided epitranscriptomic regulation.

Cell discovery·2026
Same author

Genome-guided discovery of antibiotic activity in <i>Streptomyces virginiae</i> THA-960 against multidrug resistant <i>Staphylococcus aureus</i>.

iScience·2026
Same author

Chemical-Assembled Macrophage-Engaging Glypican-3 × Signal Regulatory Protein-α (SIRP-α) Bispecific Antibody for Immunotherapy Against Liver Cancer.

MedComm·2026
Same author

A Multi-Center Study: Developing a Nomogram for Predicting Genetic Results of Trio-Based Whole-Exome Sequencing (Trio-WES) in Diagnosing Children with Syndromic Neurodevelopmental Disorders (s-NDDs).

International journal of general medicine·2026

Related Experiment Video

Updated: Aug 7, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.6K

GPMeta: a GPU-accelerated method for ultrarapid pathogen identification from metagenomic sequences.

Xuebin Wang1,2, Taifu Wang1,3, Zhihao Xie1,2

  • 1BGI Genomics, BGI-Shenzhen, Shenzhen 518083, China.

Briefings in Bioinformatics
|March 14, 2023
PubMed
Summary
This summary is machine-generated.

GPMeta is a new GPU-accelerated tool that rapidly identifies pathogens from metagenomic sequencing (mNGS) data. It offers higher accuracy and speed than existing methods, improving infectious disease diagnostics.

Keywords:
GPUsinfectious diseasemNGS testmetagenomicspathogen detection

More Related Videos

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

19.8K
Author Spotlight: A Cost-Effective Genomic Workflow for Advancing Rabies Control in Resource-Limited Settings
10:26

Author Spotlight: A Cost-Effective Genomic Workflow for Advancing Rabies Control in Resource-Limited Settings

Published on: August 18, 2023

5.3K

Related Experiment Videos

Last Updated: Aug 7, 2025

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

28.6K
Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing
08:05

Guided Protocol for Fecal Microbial Characterization by 16S rRNA-Amplicon Sequencing

Published on: March 19, 2018

19.8K
Author Spotlight: A Cost-Effective Genomic Workflow for Advancing Rabies Control in Resource-Limited Settings
10:26

Author Spotlight: A Cost-Effective Genomic Workflow for Advancing Rabies Control in Resource-Limited Settings

Published on: August 18, 2023

5.3K

Area of Science:

  • Genomics
  • Bioinformatics
  • Infectious Disease Diagnostics

Background:

  • Metagenomic sequencing (mNGS) is crucial for identifying pathogens in clinical microbiology.
  • Current methods for classifying mNGS data are often too slow for clinical use.
  • Rapid and accurate pathogen identification is essential for timely diagnosis and treatment.

Purpose of the Study:

  • To develop a novel, GPU-accelerated approach for ultrarapid pathogen identification from mNGS data.
  • To improve the speed and accuracy of pathogen classification in clinical settings.
  • To introduce a clustering algorithm (GPMetaC) for enhanced discrimination of homologous sequences.

Main Methods:

  • Developed GPMeta, a GPU-accelerated bioinformatics tool for pathogen identification.
  • Utilized mock microbial community and real clinical mNGS datasets for validation.
  • Implemented the GPMetaC clustering algorithm for improved sequence alignment and discrimination.
  • Compared GPMeta's performance against established tools like Bowtie2, Bwa, Kraken2, and Centrifuge.

Main Results:

  • GPMeta demonstrated significantly higher speed and accuracy compared to existing state-of-the-art tools.
  • The GPMetaC algorithm improved precision and recall rates for distinguishing highly homologous sequences (>95% average nucleotide identity).
  • GPMeta effectively addresses the challenge of classifying mNGS data within clinically relevant timeframes.

Conclusions:

  • GPMeta offers a powerful solution for rapid and accurate pathogen identification from mNGS data.
  • The tool is vital for advancing mNGS applications in infectious disease diagnostics requiring fast turnaround times.
  • Further research is needed to integrate GPMeta seamlessly into routine clinical workflows.